Workflow
东曜药业-B：朴欣汀推动业绩快速增长，ADC CDMO渐入佳境
01875TOT BIOPHARM(01875) 国元国际控股·2024-08-16 02:10

证 券 研 究 报 告 | --- | --- | |----------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...